EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Recent advances in long-acting drug delivery systems for anticancer drug

Catarina Pacheco, Ana Baião, Tao Ding, Wenguo Cui, Bruno Sarmento

Advanced Drug Delivery Reviews · 2023-03 · 194 · 114724

DOI: 10.1016/j.addr.2023.114724 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023-03. Verfasst von Catarina Pacheco und 4 weiteren Autor:innen. Beteiligte Einrichtung: i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; INEB - Instituto de Enge…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 192-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of systemic anticancer chemotherapy is intrinsically limited by its toxicity. Whether dealing with small molecules or biopharmaceuticals, after systemic administration, small doses fail to reach effective intratumoral concentrations, while high doses with significant tumor inhibition effects may also drive the death of healthy cells, endangering the patients. Therefore, strategies based on drug delivery systems (DDSs) for avoiding the systemic toxicity have been designed. Due to their ability to protect drugs from early elimination and control drug release, DDSs can foster tumor exposure to anticancer therapeutics by extending their circulation time or steadily releasing drugs into the tumor sites. However, approval of tailored DDSs systems for clinical use is minimal as the safety and the in vivo activity still need to be ameliorated by manipulating their physicochemical characteristics. During the last few years, several strategies have been described to improve their safety, stability, and fine-tune pharmaceuticals release kinetics. Herein, we reviewed the main DDSs, namely polymeric conjugates, nano or microparticles, hydrogels, and microneedles, explored for long-acting anticancer treatments, highlighting recently proposed modifications and their potential advantages for different anticancer therapies. Additionally, important limitations of long-acting anticancer therapies and future technology directions were also covered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansDrug Delivery SystemsPolymers

Stichwörter der Autor:innen

CancerDrug delivery systemExtended half-lifeLong-acting treatmentSustained release

Substanzen

Antineoplastic AgentsPolymers

Autor:innen und Institutionen

  • i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen 208, 4200-1…
  • Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of…

Zitieren

APA

Pacheco, C., Baião, A., Ding, T., Cui, W., & Sarmento, B. (2023). Recent advances in long-acting drug delivery systems for anticancer drug. Advanced Drug Delivery Reviews, 194, 114724. https://doi.org/10.1016/j.addr.2023.114724

Vancouver

Pacheco C, Baião A, Ding T, Cui W, Sarmento B. Recent advances in long-acting drug delivery systems for anticancer drug. Advanced Drug Delivery Reviews. 2023;194:114724. doi:10.1016/j.addr.2023.114724

BibTeX
@article{Pacheco2023,
  author = {Pacheco, Catarina and Baião, Ana and Ding, Tao and Cui, Wenguo and Sarmento, Bruno},
  title = {Recent advances in long-acting drug delivery systems for anticancer drug},
  journal = {Advanced Drug Delivery Reviews},
  year = {2023},
  volume = {194},
  pages = {114724},
  doi = {10.1016/j.addr.2023.114724}
}
Kostenlos starten →